Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis
Joshua M Hamilton,1 Karen L Johnston,2 James Simples Jnr,2 Ibrahim Turkoz,2 Lisa Lim,2 Jose Antunes,3 Camilo Obando,2 Gregory Mattingly4 1Washington State University, College of Nursing, Department of Advanced Practice & Community-Based Care, Spokane, WA, USA; 2Johnson & John...
Saved in:
Main Authors: | Hamilton JM, Johnston KL, Simples Jnr J, Turkoz I, Lim L, Antunes J, Obando C, Mattingly G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-06-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-symptomatic-and-functional-remission-with-paliperidone-palmi-peer-reviewed-fulltext-article-NDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of Clinical Manifestations and Social Functioning in Schizophrenia: A Non-interventional Observational Study of Paliperidone Palmitat Dosage Forms
by: Aleksandr M. Reznik, et al.
Published: (2024-12-01) -
One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians
by: Manchado Perero S, et al.
Published: (2025-05-01) -
Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study
by: Li H, et al.
Published: (2015-12-01) -
The effectiveness of paliperidone palmitate at the stage of stabilizing treatment of schizophrenia in the outpatient department. Clinical observation
by: M. R. Bagautdinov
Published: (2020-01-01) -
Treatment Persistence of Paliperidone Palmitate 3‐Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis
by: Akihide Wakamatsu, et al.
Published: (2025-06-01)